Moderna
MRNA
#1211
Rank
โ‚น1.323 T
Marketcap
โ‚น3,440
Share price
-3.12%
Change (1 day)
-59.61%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) Fails to deliver data

Key failure to deliver metrics for Moderna :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Moderna (MRNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Moderna (MRNA) - since 2018

Volume in USD (price x number of shares), data since 2018

Moderna (MRNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚น1.82 M-98.83%
2024โ‚น0.15 B15.08%
2023โ‚น0.13 B-50.15%
2022โ‚น0.27 B-85.7%
2021โ‚น1.90 B158.2%
2020โ‚น0.73 B369.18%
2019โ‚น0.15 B1011.49%
2018โ‚น14.15 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚น0.77 Mโ‚น6.63 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น76.76 Mโ‚น0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.09 Mโ‚น0.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น18.46 Mโ‚น45.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น81.23 Mโ‚น0.14 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น0.55 Mโ‚น8.17 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น21.76 Mโ‚น0.31 B๐Ÿ‡บ๐Ÿ‡ธ USA